This topic contains a solution. Click here to go to the answer

Author Question: An NP prescribes azelastine for a patient who has allergic rhinitis. The NP will teach the patient ... (Read 36 times)

piesebel

  • Hero Member
  • *****
  • Posts: 565
An NP prescribes azelastine for a patient who has allergic rhinitis. The NP will teach the patient that this drug:
 
  a. may cause a bitter aftertaste.
  b. will not provide maximum relief for a few weeks.
  c. will cause rebound congestion if withdrawn suddenly.
  d. can cause many systemic side effects such as drowsiness.

Question 2

A patient with primary hypercholesterolemi a is taking an HMG-CoA reductase inhibitor. All of the patient's baseline LFTs were normal. At a 6-month follow-up visit, the patient reports occasional headache.
 
  A lipid profile reveals a decrease of 20 in the patient's LDL cholesterol. The NP should: a. order LFTs.
  b. order CK-MM tests.
  c. consider decreasing the dose of the medication.
  d. reassure the patient that this side effect is common.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jaygar71

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

A
Azelastine is a topical antihistamine with few adverse systemic side effects. Patients may experience relief from symptoms within 30 minutes. Decongestants can cause rebound congestion if withdrawn suddenly. Topical antihistamines rarely cause systemic side effects.

Answer to Question 2

D
LFTs should be performed at baseline, 12 weeks after initiation of therapy, and only periodically thereafter. Headaches are common side effects, but do not raise concern about hepatotoxicity. CK-MM tests are indicated if patients report muscle pain or weakness. It is not necessary to decrease the medication.




piesebel

  • Member
  • Posts: 565
Reply 2 on: Jul 24, 2018
:D TYSM


chereeb

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Excellent

 

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Your heart beats over 36 million times a year.

For a complete list of videos, visit our video library